Varicella-Zoster Virus Testing in Clinical Practice in the U.S., 2016–2023
- 30 March 2025
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (1) , 107627
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
- U.S. Department of Health and Human Services
This publication has 13 references indexed in Scilit:
- Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and RubellaAmerican Journal of Preventive Medicine, 2024
- Current Methods for the Detection of Antibodies of Varicella-Zoster Virus: A ReviewMicroorganisms, 2023
- Celebrating 25 Years of Varicella Vaccination Coverage for Children and Adolescents in the United States: A Success StoryThe Journal of Infectious Diseases, 2022
- 25 Years of Varicella Vaccination in the United StatesThe Journal of Infectious Diseases, 2022
- Monitoring Varicella Vaccine Impact on Varicella Incidence in the United States: Surveillance Challenges and Changing Epidemiology, 1995–2019The Journal of Infectious Diseases, 2022
- Extensive CD4 and CD8 T Cell Cross-Reactivity between AlphaherpesvirusesThe Journal of Immunology, 2016
- Practice Bulletin No. 151Obstetrics & Gynecology, 2015
- Varicella Seroprevalence in the U.S.: Data from the National Health and Nutrition Examination Survey, 1999–2004Public Health Reports®, 2010
- Evaluation of Laboratory Methods for Diagnosis of VaricellaClinical Infectious Diseases, 2010
- HSV-1 gB and VZV gp-II crossreactive antibodies in human seraArchives of Virology, 1990